Yakira Capital Management, Inc. - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
Yakira Capital Management, Inc. ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$323,0000.0%17,5880.0%0.08%
-18.9%
Q3 2020$323,00017,5880.10%
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q1 2021.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders